Abstract
Coronavirus disease 2019 (COVID-19) emerged in Wuhan City and rapidly spread throughout China and around the world since December 2019 [1]. The World Health Organization (WHO) declared the COVID-19 outbreak a global pandemic on 11 March 2020 [2, 3].
Patients with metabolic disorders like cardiovascular diseases, diabetes and obesity may face a greater risk of infection of COVID-19 and it can also greatly affect the development and prognosis of pneumonia [1, 4,5,6].
In response to the COVID-19 pandemic outbreak, the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has issued these recommendations to our global healthcare providers aimed at keeping all our patients and practice staff in an as safe an environment as possible.
Patients with metabolic disorders like cardiovascular diseases, diabetes and obesity may face a greater risk of infection of COVID-19 and it can also greatly affect the development and prognosis of pneumonia [1, 4,5,6].
In response to the COVID-19 pandemic outbreak, the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has issued these recommendations to our global healthcare providers aimed at keeping all our patients and practice staff in an as safe an environment as possible.
| Original language | English |
|---|---|
| Pages (from-to) | 2071-2073 |
| Number of pages | 3 |
| Journal | Obesity Surgery |
| Volume | 30 |
| Issue number | 6 |
| Early online date | 14 Apr 2020 |
| DOIs | |
| Publication status | Published - Jun 2020 |
| Externally published | Yes |
Keywords
- Bariatric surgery
- COVID-19
- IFSO
- Metabolic disorder
